Thrive Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Sell
3,745
-679
-15% -$54.8K 0.04% 197
2026
Q1
$383K Sell
4,424
-1,145
-21% -$110K 0.06% 146
2025
Q4
$535K Buy
5,569
+193
+4% +$18.7K 0.08% 123
2025
Q3
$512K Sell
5,376
-9
-0.2% -$827 0.08% 124
2025
Q2
$469K Sell
5,385
-185
-3% -$15.7K 0.08% 130
2025
Q1
$501K Buy
5,570
+110
+2% +$9.84K 0.1% 113
2024
Q4
$436K Sell
5,460
-556
-9% -$48.1K 0.08% 128
2024
Q3
$542K Buy
6,016
+22
+0.4% +$1.85K 0.1% 107
2024
Q2
$472K Sell
5,994
-262
-4% -$21.5K 0.09% 111
2024
Q1
$545K Sell
6,256
-328
-5% -$28K 0.11% 97
2023
Q4
$542K Buy
6,584
+3,235
+97% +$247K 0.12% 100
2023
Q3
$262K Sell
3,349
-594
-15% -$49.7K 0.07% 137
2023
Q2
$347K Buy
+3,943
New +$339K 0.09% 122

Other funds holding MDT

Thrive Wealth Management's MDT Position: Q2 2026 in Review

Thrive Wealth Management reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $54.8K and leaving 3,745 shares worth $293K. The position accounts for 0.04% of the portfolio, ranked #197.

Thrive Wealth Management first reported a position in MDT in Q2 2023 and has held it in 13 quarters since. The position peaked at $545K in Q1 2024. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Thrive Wealth Management held 3,745 shares of Medtronic worth $293K as of Q2 2026.
  • Thrive Wealth Management sold 679 Medtronic shares in Q2 2026, an estimated $54.8K.
  • Medtronic made up 0.04% of Thrive Wealth Management's portfolio in Q2 2026, its #197 holding.
  • Thrive Wealth Management first reported a position in Medtronic in Q2 2023 and has held it in 13 quarters since.
  • Thrive Wealth Management's Medtronic position peaked at $545K in Q1 2024.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.